Download India's most affordable pharmacy app
- Compare with medicine prices
- Save upto 90% on your medicine bills
COMPOSITION:
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)DESCRIPTION:
Introduction
Ozomet-VG2 Tablet SR is a combination medication used primarily for managing Type 2 Diabetes Mellitus. It contains Metformin Hydrochloride and Glimepiride in a sustained-release (SR) formulation.
Uses
- Management of Type 2 Diabetes Mellitus
- Helps to control blood sugar levels in patients who cannot manage with diet and exercise alone
How it Works
Ozomet-VG2 Tablet SR works by combining two actions:
- Metformin reduces the amount of glucose released by the liver and increases the body’s sensitivity to insulin.
- Glimepiride stimulates the pancreas to produce more insulin, which helps lower blood sugar levels.
Benefits
- Effective in controlling blood sugar levels
- Reduces the risk of long-term complications of diabetes
- Improves insulin sensitivity and glucose utilization
How to Take
- Take one tablet once daily, preferably with a meal.
- Swallow the tablet whole; do not crush or chew.
- Follow the dosage and timing as prescribed by your healthcare provider.
Side Effects
- Common side effects include nausea, stomach discomfort, and diarrhea.
- Low blood sugar levels (hypoglycemia) may occur.
- May cause weight gain in some cases.
Safety Advice
- Use under medical supervision.
- Regular monitoring of blood sugar levels is essential.
- Report any symptoms of low or high blood sugar immediately.
- Avoid alcohol consumption, as it may interfere with the medication's effectiveness.
Frequently Asked Questions
Q: Can Ozomet-VG2 Tablet SR be taken with other diabetes medications?
A: Only under the supervision of a healthcare provider. Combining medications requires monitoring.
Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember, but do not double the next dose.
Q: Can this tablet cause weight gain?
A: Weight gain is a potential side effect, but it varies from person to person.